ID   ARHG9_RAT               Reviewed;         493 AA.
AC   Q9QX73; Q9ER22;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-OCT-2024, entry version 140.
DE   RecName: Full=Rho guanine nucleotide exchange factor 9;
DE   AltName: Full=Collybistin;
DE   AltName: Full=Rac/Cdc42 guanine nucleotide exchange factor 9;
GN   Name=Arhgef9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, INTERACTION WITH
RP   GPHN, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10607391; DOI=10.1038/71096;
RA   Kins S., Betz H., Kirsch J.;
RT   "Collybistin, a newly identified brain-specific GEF, induces submembrane
RT   clustering of gephyrin.";
RL   Nat. Neurosci. 3:22-29(2000).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH GPHN, AND MUTAGENESIS OF
RP   ARG-107; ASP-108; ARG-111 AND GLU-117.
RX   PubMed=11727829; DOI=10.1515/bc.2001.179;
RA   Grosskreutz Y., Hermann A., Kins S., Fuhrmann J.C., Betz H., Kneussel M.;
RT   "Identification of a gephyrin-binding motif in the GDP/GTP exchange factor
RT   collybistin.";
RL   Biol. Chem. 382:1455-1462(2001).
RN   [3]
RP   ALTERNATIVE SPLICING, FUNCTION, INTERACTION WITH GPHN, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15215304; DOI=10.1523/jneurosci.1184-04.2004;
RA   Harvey K., Duguid I.C., Alldred M.J., Beatty S.E., Ward H., Keep N.H.,
RA   Lingenfelter S.E., Pearce B.R., Lundgren J., Owen M.J., Smart T.G.,
RA   Luescher B., Rees M.I., Harvey R.J.;
RT   "The GDP-GTP exchange factor collybistin: an essential determinant of
RT   neuronal gephyrin clustering.";
RL   J. Neurosci. 24:5816-5826(2004).
RN   [4]
RP   MUTAGENESIS OF ARG-297.
RX   PubMed=25678704; DOI=10.1074/jbc.m114.633024;
RA   Papadopoulos T., Schemm R., Grubmueller H., Brose N.;
RT   "Lipid binding defects and perturbed synaptogenic activity of a
RT   collybistinR290H mutant that causes epilepsy and intellectual disability.";
RL   J. Biol. Chem. 290:8256-8270(2015).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 10-411 IN COMPLEX WITH CDC42, AND
RP   MUTAGENESIS OF ARG-107; ASP-108; ARG-111 AND GLU-117.
RX   PubMed=16616186; DOI=10.1016/j.jmb.2006.03.019;
RA   Xiang S., Kim E.Y., Connelly J.J., Nassar N., Kirsch J., Winking J.,
RA   Schwarz G., Schindelin H.;
RT   "The crystal structure of Cdc42 in complex with collybistin II, a gephyrin-
RT   interacting guanine nucleotide exchange factor.";
RL   J. Mol. Biol. 359:35-46(2006).
CC   -!- FUNCTION: Acts as a guanine nucleotide exchange factor (GEF) for CDC42.
CC       Promotes formation of GPHN clusters. {ECO:0000269|PubMed:10607391,
CC       ECO:0000269|PubMed:11727829, ECO:0000269|PubMed:15215304}.
CC   -!- SUBUNIT: Interacts with GPHN. {ECO:0000269|PubMed:10607391,
CC       ECO:0000269|PubMed:11727829, ECO:0000269|PubMed:15215304,
CC       ECO:0000269|PubMed:16616186}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10607391,
CC       ECO:0000269|PubMed:11727829, ECO:0000269|PubMed:15215304}. Postsynaptic
CC       density {ECO:0000250|UniProtKB:Q3UTH8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Collybistin I;
CC         IsoId=Q9QX73-1; Sequence=Displayed;
CC       Name=2; Synonyms=Collybistin II;
CC         IsoId=Q9QX73-2; Sequence=VSP_021147, VSP_021148;
CC   -!- TISSUE SPECIFICITY: Detected in brain, throughout the gray matter.
CC       Detected at low levels in heart and skeletal muscle.
CC       {ECO:0000269|PubMed:10607391}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ250425; CAB65966.1; -; mRNA.
DR   EMBL; AJ302676; CAC16410.1; -; mRNA.
DR   RefSeq; NP_076447.1; NM_023957.1.
DR   PDB; 2DFK; X-ray; 2.15 A; A/C=71-463.
DR   PDB; 4MT6; X-ray; 5.50 A; A=1-456.
DR   PDB; 4MT7; X-ray; 3.50 A; A=10-493.
DR   PDBsum; 2DFK; -.
DR   PDBsum; 4MT6; -.
DR   PDBsum; 4MT7; -.
DR   AlphaFoldDB; Q9QX73; -.
DR   SMR; Q9QX73; -.
DR   IntAct; Q9QX73; 1.
DR   MINT; Q9QX73; -.
DR   PhosphoSitePlus; Q9QX73; -.
DR   ABCD; Q9QX73; 2 sequenced antibodies.
DR   GeneID; 66013; -.
DR   KEGG; rno:66013; -.
DR   AGR; RGD:620719; -.
DR   CTD; 23229; -.
DR   RGD; 620719; Arhgef9.
DR   InParanoid; Q9QX73; -.
DR   OrthoDB; 24739at2759; -.
DR   PhylomeDB; Q9QX73; -.
DR   Reactome; R-RNO-193648; NRAGE signals death through JNK.
DR   Reactome; R-RNO-416482; G alpha (12/13) signalling events.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   Reactome; R-RNO-9013406; RHOQ GTPase cycle.
DR   Reactome; R-RNO-977443; GABA receptor activation.
DR   EvolutionaryTrace; Q9QX73; -.
DR   PRO; PR:Q9QX73; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005938; C:cell cortex; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IEA:GOC.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0099572; C:postsynaptic specialization; IDA:SynGO.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0043113; P:receptor clustering; IDA:RGD.
DR   GO; GO:0099150; P:regulation of postsynaptic specialization assembly; ISO:RGD.
DR   CDD; cd01224; PH_Collybistin_ASEF; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd11975; SH3_ARHGEF9; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   IDEAL; IID50103; -.
DR   InterPro; IPR035728; ARHGEF9_SH3.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR47544; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4; 1.
DR   PANTHER; PTHR47544:SF2; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 9; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   Pfam; PF22697; SOS1_NGEF_PH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm;
KW   Guanine-nucleotide releasing factor; Reference proteome; SH3 domain;
KW   Synapse.
FT   CHAIN           1..493
FT                   /note="Rho guanine nucleotide exchange factor 9"
FT                   /id="PRO_0000253898"
FT   DOMAIN          15..74
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          110..294
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          325..432
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          107..117
FT                   /note="Interaction with GPHN"
FT   REGION          453..473
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         12..71
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10607391"
FT                   /id="VSP_021147"
FT   VAR_SEQ         464..493
FT                   /note="GRVGEEENQSLELKRACEVLQRLWSPGKKS -> VTQRKWHY (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10607391"
FT                   /id="VSP_021148"
FT   MUTAGEN         107
FT                   /note="R->A: No effect on formation of GPHN clusters; when
FT                   associated with A-108 and A-117."
FT                   /evidence="ECO:0000269|PubMed:11727829,
FT                   ECO:0000269|PubMed:16616186"
FT   MUTAGEN         108
FT                   /note="D->A: No effect on GPHN clusters; when associated
FT                   with A-107 and A-117."
FT                   /evidence="ECO:0000269|PubMed:11727829,
FT                   ECO:0000269|PubMed:16616186"
FT   MUTAGEN         111
FT                   /note="R->A: Loss of formation of GPHN clusters."
FT                   /evidence="ECO:0000269|PubMed:11727829,
FT                   ECO:0000269|PubMed:16616186"
FT   MUTAGEN         117
FT                   /note="E->A: No effect on GPHN clusters; when associated
FT                   with A-107 and A-108."
FT                   /evidence="ECO:0000269|PubMed:11727829,
FT                   ECO:0000269|PubMed:16616186"
FT   MUTAGEN         297
FT                   /note="R->H: Defects in binding to phosphatidylinositol-3-
FT                   phosphate and in formation of GPHN clusters."
FT                   /evidence="ECO:0000269|PubMed:25678704"
FT   HELIX           107..135
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           137..142
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   TURN            144..146
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           149..156
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           159..176
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           182..184
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           188..193
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   TURN            194..196
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           197..199
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           200..218
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           222..234
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           242..246
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           248..265
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           274..299
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           301..310
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          311..313
FT                   /evidence="ECO:0007829|PDB:4MT7"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          326..337
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          343..350
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          353..359
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          367..374
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           375..377
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          378..382
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          385..387
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          389..391
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          394..407
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   STRAND          409..413
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           417..440
FT                   /evidence="ECO:0007829|PDB:2DFK"
FT   HELIX           446..458
FT                   /evidence="ECO:0007829|PDB:2DFK"
SQ   SEQUENCE   493 AA;  58157 MW;  41040671B9398BFA CRC64;
     MQWIRGGSGM LITGDSIVSA EAVWDHVTMA NRGVAFKAGD VIKVLDASNK DWWWGQIDDE
     EGWFPASFVR LWVNQEDGVE EGPSDVQNGH LDPNSDCLCL GRPLQNRDQM RANVINEIMS
     TERHYIKHLK DICEGYLKQC RKRRDMFSDE QLKVIFGNIE DIYRFQMGFV RDLEKQYNND
     DPHLSEIGPC FLEHQDGFWI YSEYCNNHLD ACMELSKLMK DSRYQHFFEA CRLLQQMIDI
     AIDGFLLTPV QKICKYPLQL AELLKYTAQD HSDYRYVAAA LAVMRNVTQQ INERKRRLEN
     IDKIAQWQAS VLDWEGDDIL DRSSELIYTG EMAWIYQPYG RNQQRVFFLF DHQMVLCKKD
     LIRRDILYYK GRIDMDKYEV IDIEDGRDDD FNVSMKNAFK LHNKETEEVH LFFAKKLEEK
     IRWLRAFREE RKMVQEDEKI GFEISENQKR QAAMTVRKAS KQKGRVGEEE NQSLELKRAC
     EVLQRLWSPG KKS
//
